Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Linkesch

Showing results (61-70 of 141) with videos related to

Pageof 15
Sort By:
International Journal of Sports Medicine|August 1, 1993
A rare complication of a central venous catheter system (Port-a-Cath). A case report of a catheter embolization after catheter fracture during power trainingG Röggla, M Linkesch, M Röggla, et al.
European Journal of Clinical Investigation|October 1, 1988
Asparaginase-induced derangements of glutamine metabolism: the pathogenetic basis for some drug-related side-effectsG Ollenschläger, E Roth, W Linkesch, et al.
Lancet (London, England)|March 25, 1989
Long-term interferon therapy for thrombocytosis in myeloproliferative diseasesH Gisslinger, H Ludwig, W Linkesch, et al.
Annals of Hematology|June 28, 2000
Acute myelofibrosis: multifocal bone marrow infiltration detected by scintigraphy and magnetic resonance imagingW Olipitz, C Beham-Schmid, R Aigner, et al.
Wiener Klinische Wochenschrift|November 4, 1988
[Defects in the prostaglandin system. VIII. A pathologic thrombocyte population in myeloproliferative syndrome, which forms no thromboxane from exogenous arachidonic acid]H Sinzinger, H Gisslinger, W Linkesch, et al.
Annals of Hematology|April 6, 2005
Evaluation of potential risk factors for early infectious complications after autologous peripheral blood stem cell transplantation in patients with lymphoproliferative diseasesH W Auner, A Zebisch, P Ofner, et al.
Journal of Interferon Research|April 1, 1990
Effect of recombinant interferon-alpha2C on reticuloendothelial function in patients with thrombocytosisW Scheithauer, H Gisslinger, E M Temsch, et al.
Annals of Hematology|March 23, 2001
Hepatic veno-occlusive disease in two patients with relapsed acute myeloid leukemia treated with anti-CD33 calicheamicin (CMA-676) immunoconjugateP Neumeister, M Eibl, W Zinke-Cerwenka, et al.
Prostaglandins|October 1, 1990
Impaired conversion of exogenous arachidonic acid by platelets to thromboxane B2 and correction of that deficiency by interferon-alphaH Sinzinger, W Linkesch, H Ludwig, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|March 1, 1995
In vivo administration of granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor increases neutrophil oxidative burst activityC Wiltschke, M Krainer, M Nanut, et al.
Pageof 15

Showing results (61-70 of 141) with videos related to

Sort By:
Pageof 15
International Journal of Sports Medicine|August 1, 1993
A rare complication of a central venous catheter system (Port-a-Cath). A case report of a catheter embolization after catheter fracture during power trainingG Röggla, M Linkesch, M Röggla, et al.
European Journal of Clinical Investigation|October 1, 1988
Asparaginase-induced derangements of glutamine metabolism: the pathogenetic basis for some drug-related side-effectsG Ollenschläger, E Roth, W Linkesch, et al.
Lancet (London, England)|March 25, 1989
Long-term interferon therapy for thrombocytosis in myeloproliferative diseasesH Gisslinger, H Ludwig, W Linkesch, et al.
Annals of Hematology|June 28, 2000
Acute myelofibrosis: multifocal bone marrow infiltration detected by scintigraphy and magnetic resonance imagingW Olipitz, C Beham-Schmid, R Aigner, et al.
Wiener Klinische Wochenschrift|November 4, 1988
[Defects in the prostaglandin system. VIII. A pathologic thrombocyte population in myeloproliferative syndrome, which forms no thromboxane from exogenous arachidonic acid]H Sinzinger, H Gisslinger, W Linkesch, et al.
Annals of Hematology|April 6, 2005
Evaluation of potential risk factors for early infectious complications after autologous peripheral blood stem cell transplantation in patients with lymphoproliferative diseasesH W Auner, A Zebisch, P Ofner, et al.
Journal of Interferon Research|April 1, 1990
Effect of recombinant interferon-alpha2C on reticuloendothelial function in patients with thrombocytosisW Scheithauer, H Gisslinger, E M Temsch, et al.
Annals of Hematology|March 23, 2001
Hepatic veno-occlusive disease in two patients with relapsed acute myeloid leukemia treated with anti-CD33 calicheamicin (CMA-676) immunoconjugateP Neumeister, M Eibl, W Zinke-Cerwenka, et al.
Prostaglandins|October 1, 1990
Impaired conversion of exogenous arachidonic acid by platelets to thromboxane B2 and correction of that deficiency by interferon-alphaH Sinzinger, W Linkesch, H Ludwig, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|March 1, 1995
In vivo administration of granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor increases neutrophil oxidative burst activityC Wiltschke, M Krainer, M Nanut, et al.
Pageof 15